BNP Paribas Financial Markets’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $559K | Buy |
17,844
+14,634
| +456% | +$458K | ﹤0.01% | 2509 |
|
|
2025
Q1 | $108K | Sell |
3,210
-122
| -4% | -$4.09K | ﹤0.01% | 3184 |
|
|
2024
Q4 | $131K | Sell |
3,332
-140
| -4% | -$5.49K | ﹤0.01% | 3224 |
|
|
2024
Q3 | $137K | Sell |
3,472
-8,144
| -70% | -$321K | ﹤0.01% | 2664 |
|
|
2024
Q2 | $453K | Buy |
11,616
+3,295
| +40% | +$128K | ﹤0.01% | 2076 |
|
|
2024
Q1 | $358K | Buy |
8,321
+3,931
| +90% | +$169K | ﹤0.01% | 2373 |
|
|
2023
Q4 | $202K | Buy |
4,390
+2,707
| +161% | +$125K | ﹤0.01% | 2505 |
|
|
2023
Q3 | $57.5K | Buy |
1,683
+242
| +17% | +$8.27K | ﹤0.01% | 2762 |
|
|
2023
Q2 | $55.5K | Buy |
1,441
+413
| +40% | +$15.9K | ﹤0.01% | 2817 |
|
|
2023
Q1 | $36.8K | Sell |
1,028
-498
| -33% | -$17.8K | ﹤0.01% | 2837 |
|
|
2022
Q4 | $60.2K | Sell |
1,526
-3,430
| -69% | -$135K | ﹤0.01% | 2728 |
|
|
2022
Q3 | $179K | Buy |
4,956
+2,212
| +81% | +$79.9K | ﹤0.01% | 2845 |
|
|
2022
Q2 | $83.5K | Buy |
2,744
+1,410
| +106% | +$42.9K | ﹤0.01% | 2777 |
|
|
2022
Q1 | $40.8K | Buy |
1,334
+1,254
| +1,568% | +$38.3K | ﹤0.01% | 3022 |
|
|
2021
Q4 | $2.5K | Sell |
80
-422
| -84% | -$13.2K | ﹤0.01% | 3327 |
|
|
2021
Q3 | $7.67K | Buy |
502
+12
| +2% | +$183 | ﹤0.01% | 3084 |
|
|
2021
Q2 | $9.12K | Buy |
490
+261
| +114% | +$4.86K | ﹤0.01% | 3150 |
|
|
2021
Q1 | $4.1K | Buy |
+229
| New | +$4.1K | ﹤0.01% | 3302 |
|
|
2020
Q4 | – | Sell |
-95
| Closed | -$1.05K | – | 3535 |
|
|
2020
Q3 | $1.05K | Buy |
+95
| New | +$1.05K | ﹤0.01% | 3454 |
|